Frequency of migraine headaches in patients with fibromyalgia

Headache

Volumn 55, Issue 6, 2015, Pages 860-865

  Vij, Brinder ^a   Whipple, Mary O ^b   Tepper, Stewart J ^a   Mohabbat, Arya B ^b   Stillman, Mark ^a   Vincent, Ann ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

central sensitization; chronic pain; fibromyalgia; headache; ID Migraine; migraine

Indexed keywords

ADULT; ARTICLE; ASTHMA; CHRONIC FATIGUE SYNDROME; CLINICAL OBSERVATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; FEMALE; FIBROMYALGIA; HEADACHE; HUMAN; HYPERTENSION; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MIGRAINE HEADACHE; POSTTRAUMATIC STRESS DISORDER; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; AGED; COHORT ANALYSIS; MIDDLE AGED; MIGRAINE DISORDERS; REGISTER;

ADULT; AGED; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; FIBROMYALGIA; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; REGISTRIES;

EID: 84931578473     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/head.12590     Document Type: Article

References (27)

1. Lanteri-Minet M,. Economic burden and costs of chronic migraine. Curr Pain Headache Rep. 2014; 18: 385.
2. Smitherman TA, Burch R, Sheikh H, Loder E,. The prevalence, impact, and treatment of migraine and severe headaches in the United States: A review of statistics from national surveillance studies. Headache. 2013; 53: 427-436.
3. Stovner L, Hagen K, Jensen R, et-al. The global burden of headache: A documentation of headache prevalence and disability worldwide. Cephalalgia. 2007; 27: 193-210.
4. Buse DC, Loder EW, Gorman JA, et-al. Sex differences in the prevalence, symptoms, and associated features of migraine, probable migraine and other severe headache: Results of the American Migraine Prevalence and Prevention (AMPP) Study. Headache. 2013; 53: 1278-1299.
5. de Tommaso M, Federici A, Serpino C, et-al. Clinical features of headache patients with fibromyalgia comorbidity. J Headache Pain. 2011; 12: 629-638.
6. Ifergane G, Buskila D, Simiseshvely N, Zeev K, Cohen H,. Prevalence of fibromyalgia syndrome in migraine patients. Cephalalgia. 2006; 26: 451-456.
7. Kucuksen S, Genc E, Yilmaz H, et-al. The prevalence of fibromyalgia and its relation with headache characteristics in episodic migraine. Clin Rheumatol. 2013; 32: 983-990.
8. Marcus DA, Bhowmick A,. Fibromyalgia comorbidity in a community sample of adults with migraine. Clin Rheumatol. 2013; 32: 1553-1556.
9. Poyhia R, Da Costa D, Fitzcharles MA,. Previous pain experience in women with fibromyalgia and inflammatory arthritis and nonpainful controls. J Rheumatol. 2001; 28: 1888-1891.
10. Evans RW, de Tommaso M,. Migraine and fibromyalgia. Headache. 2011; 51: 295-299.
11. Valenca MM, Medeiros FL, Martins HA, Massaud RM, Peres MF,. Neuroendocrine dysfunction in fibromyalgia and migraine. Curr Pain Headache Rep. 2009; 13: 358-364.
12. Marcus DA, Bernstein C, Rudy TE,. Fibromyalgia and headache: An epidemiological study supporting migraine as part of the fibromyalgia syndrome. Clin Rheumatol. 2005; 24: 595-601.
13. Whipple MO, McAllister SJ, Oh TH, Luedtke CA, Toussaint LL, Vincent A,. Construction of a US fibromyalgia registry using the Fibromyalgia Research Survey criteria. Clin Transl Sci. 2013; 6: 398-399.
14. Wolfe F, Clauw DJ, Fitzcharles MA, et-al. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: A modification of the ACR preliminary diagnostic criteria for fibromyalgia. J Rheumatol. 2011; 38: 1113-1122.
15. Lipton RB, Dodick D, Sadovsky R, et-al. A self-administered screener for migraine in primary care: The ID Migraine validation study. Neurology. 2003; 61: 375-382.
16. Rapoport AM, Bigal ME,. ID-migraine. Neurol Sci. 2004; 25 (Suppl. 3): S258-S260.
17. Clauw DJ,. Fibromyalgia: A clinical review. J Am Med Assoc. 2014; 311: 1547-1555.
18. Clauw DJ,. The science of fibromyalgia. Mayo Clin Proc. 2011; 86: 907-911.
19. de Tommaso M, Sardaro M, Vecchio E, Serpino C, Stasi M, Ranieri M,. Central sensitisation phenomena in primary headaches: Overview of a preventive therapeutic approach. CNS Neurol Disord Drug Targets. 2008; 7: 524-535.
20. Pujol J, Lopez-Sola M, Ortiz H, et-al. Mapping brain response to pain in fibromyalgia patients using temporal analysis of fMRI. PLoS ONE. 2009; 4: e5224.
21. Vincent A, Whipple MO, McAllister SJ, Aleman K, St. Sauver JL,. A cross-sectional assessment of the prevalence of multiple conditions and medication use in a sample of community-dwelling adults with fibromyalgia in Olmsted County, Minnesota. BMJ Open. 2015; 5: e006681.
22. Arnold LM, Hudson JI, Keck PE, Auchenbach MB, Javaras KN, Hess EV,. Comorbidity of fibromyalgia and psychiatric disorders. J Clin Psychiatry. 2006; 67: 1219-1225.
23. Buskila D, Cohen H,. Comorbidity of fibromyalgia and psychiatric disorders. Curr Pain Headache Rep. 2007; 11: 333-338.
24. Przekop P, Haviland MG, Zhao Y, Oda K, Morton KR, Fraser GE,. Self-reported physical health, mental health, and comorbid diseases among women with irritable bowel syndrome, fibromyalgia, or both compared with healthy control respondents. J Am Osteopath Assoc. 2012; 112: 726-735.
25. Weir PT, Harlan GA, Nkoy FL, et-al. The incidence of fibromyalgia and its associated comorbidities: A population-based retrospective cohort study based on International Classification of Diseases, 9th revision codes. J Clin Rheumatol. 2006; 12: 124-128.
26. White LA, Birnbaum HG, Kaltenboeck A, Tang J, Mallett D, Robinson RL,. Employees with fibromyalgia: Medical comorbidity, healthcare costs, and work loss. J Occup Environ Med. 2008; 50: 13-24.
27. Kararizou E, Anagnostou E, Triantafyllou NI,. Dramatic improvement of fibromyalgia symptoms after treatment with topiramate for coexisting migraine. J Clin Psychopharmacol. 2013; 33: 721-723.